Pharmacologic Principles Part 1: Pharmaceutics, Pharmacokinetics Flashcards
Study of drugs (pharmacokinetics and pharmacodynamics)
Pharmakon or Pharmacology
Pharmacology
Comes from Greek word “Pharmakon”
Pharmakon or Pharmacology
Pharmacology
Means drug(remedy) and poison
Pharmakon or Pharmacology
Pharmakon
Drug affects the body
PHARMACOKINETICS, PHARMACEUTICS, or PHARMACODYNAMICS
PHARMACEUTICS
Body does to the drug
PHARMACOKINETICS, PHARMACEUTICS, or PHARMACODYNAMICS
PHARMACOKINETICS
Drug does to the body
PHARMACOKINETICS, PHARMACEUTICS, or PHARMACODYNAMICS
PHARMACODYNAMICS
“Peanut Butter”
PHARMACOKINETICS, PHARMACEUTICS, or PHARMACODYNAMICS
PHARMACOKINETICS
“Jelly”
PHARMACOKINETICS, PHARMACEUTICS, or PHARMACODYNAMICS
PHARMACODYNAMICS
Drug absorption fast to slowest.
a. Enteric Coated Tablets
b. Capsules
c. Oral disintegration, Buccal Tablets, & Oral Soluble Wafers
d. Powder
e. Tablets
f. Liquids, elixers, & syrups
g. Coated Tablets
h. Suspension Solution
c. Oral disintegration, Buccal Tablets, & Oral Soluble Wafers
f. Liquids, elixers, & syrups
h. Suspension Solution
d. Powder
b. Capsules
e. Tablets
g. Coated Tablets
a. Enteric Coated Tablets
Already in dissolved form and thus absorbed quickly
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Oral Liquids/Suspensions
b. Oral Liquids/Suspensions
Extra coating on the outside prevents drug from being broken down by the acidic pH of the
stomach
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Enteric Coated Tablets
a. Enteric Coated Tablets
Drug is not absorbed until they reach the small intestine (higher pH)
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Enteric Coated Tablets
a. Enteric Coated Tablets
Commonly made to PROTECT the gastric mucosa from irritation
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Enteric Coated Tablets
a. Enteric Coated Tablets
Release drug over a prolonged period of time
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Extended Release/Sustained Release Tablets
e. Extended Release/Sustained Release Tablets
◦ Abbreviations => EC
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Enteric Coated Tablets
a. Enteric Coated Tablets
◦ Abbreviations => SR, SA, CR, XL, XT, ER, and more
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Extended Release/Sustained Release Tablets
e. Extended Release/Sustained Release Tablets
Sublingual, Buccal
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Oral Mucosa Absorption
d. Oral Mucosa Absorption
Absorbed through surface of the skin
◦ Skin, Eyes, Ears, Nose, Rectum, Vagina, Lungs and more
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Topical/Transdermal
f. Topical/Transdermal
IV formulations must have similar pH to blood, otherwise damage can happen to veins/arteries
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Parenteral (Injectable)
c. Parenteral (Injectable)
◦ Drug is immediately in solution (no need to dissolve)
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Parenteral (Injectable)
c. Parenteral (Injectable)
◦ Therefore drug is 100% absorbed and ready to work!
a. Enteric Coated Tablets
b. Oral Liquids/Suspensions
c. Parenteral (Injectable)
d. Oral Mucosa Absorption
e. Extended Release/Sustained Release Tablets
f. Topical/Transdermal
Parenteral (Injectable)
c. Parenteral (Injectable)
PHARMACOKINETICS body does to the drug (ADME) A- D- M- E-
Absorption
Distribution
Metabolism
Elimination/Excretion
ADME
PHARMACOKINETICS, PHARMACEUTICS, or PHARMACODYNAMICS
PHARMACOKINETICS
Study of what happens to a parent drug from the time it is put into the body until the parent drug and all metabolites have left the body
Nursing process, ADME, QSEN, or IPEC
ADME
Movement of a drug from its site of administration into the bloodstream for distribution to the tissues
Elimination/Excretion
Distribution
Absorption
Metabolism
Absorption
Bioavailability
First Pass Effect
P-Glycoprotein
Routes
Elimination/Excretion
Distribution
Absorption
Metabolism
Absorption
Percentage of how much active drug reaches the bloodstream
P-Glycoprotein
Bioavailability
Routes
First Pass Effect
Bioavailability
Which is true Oral Route is 100% Bioavailable IV Route is 100% Bioavailable Oral Route is variable IV Route is variable
IV Route is 100% Bioavailable
Oral Route is variable
What influences bioavailability?
a. P-Glycoproteins
b. First Pass Effect
c. Oral Route/GI Tract factor
d. And more!
e. None
f. All
f. All
First Pass Effect in order
a. Metabolized drug reaches general blood circulation
b. Drugs can get absorbed in GI tract
▪ gastric mucosa (stomach)
▪ Intestinal mucosa (small intestines)
c. The gastric/intestinal mucosal blood flow goes to portal vein
d. Swallow the drug orally
e. Portal Vein carries the blood to the Liver
f. Liver metabolizes drugs (FIRST PASS EFFECT)
g. Drug travels down the GI tract
d. Swallow the drug orally
g. Drug travels down the GI tract
b. Drugs can get absorbed in GI tract
▪ gastric mucosa (stomach)
▪ Intestinal mucosa (small intestines)
c. The gastric/intestinal mucosal blood flow goes to portal vein
e. Portal Vein carries the blood to the Liver
f. Liver metabolizes drugs (FIRST PASS EFFECT)
a. Metabolized drug reaches general blood circulation
Mouth- Stomach- Small Intestines- Large Intestines- Rectum-
Liver or GBC (General Blood Circulation)
Mouth- GBC Stomach- Liver Small Intestines- Liver Large Intestines- Liver Rectum- GBC
Part of our “defense system”
a. P-Glycoproteins
b. First Pass Effect
c. Oral Route/GI Tract factor
d. And more!
e. None
f. All
a. P-Glycoproteins
Located in essentials areas of body
◦ Blood Brain Barrier, GI Tract
a. P-Glycoproteins
b. First Pass Effect
c. Oral Route/GI Tract factor
d. And more!
e. None
f. All
a. P-Glycoproteins
Called - “Anti-absorption pumps” or Efflux Pumps
a. P-Glycoproteins
b. First Pass Effect
c. Oral Route/GI Tract factor
d. And more!
e. None
f. All
a. P-Glycoproteins
▪P-glycoproteins (More or Less)
a. Net Result= More absorption of drugs into the general circulation
b. Net Result= Less absorption of drugs into the general circulation
Less
b. Net Result= Less absorption of drugs into the general circulation
P-Glycoprotein
Inhibitor or Inducer?
Inhibitor
P-Glycoprotein Inhibitor:
Cranberry Juice
Grape Fruit
Grape Fruit
The drug is absorbed into the systemic circulation through the GI tract
Enteral or Parental
Enteral
Oral
Sublingual/Buccal
Suppositories
Enteral or Parental
Enteral
The most common of all routes is the ORAL ROUTE
▪ Most drugs are ABSORBED in stomach or small intestine
Enteral or Parental
Enteral
What can influence ORAL route ABSORPTION?
a. pH of the GI tract
b. Drugs or Meals
c. Drug Formulation
d. None
a. pH of the GI tract
b. Drugs or Meals
c. Drug Formulation
◦ Drug is placed under the tongue
Buccal or Sublingual
Sublingual
◦ Drug is placed between the cheek and gum
Buccal or Sublingual
Buccal
◦ EXAMPLE: NitroSTAT- Nitroglycerin tablets used for acute chest pain (heart attack or angina)
Buccal or Sublingual
Sublingual
◦ EXAMPLE: Actiq®- Essentially a fentanyl lollipop for acute, extreme breakthrough cancer pain
Buccal or Sublingual
Buccal
Key Points: For Buccal & Sublingual
a. Drug is absorbed in the oral mucosa of the mouth and goes directly into the blood stream
b. Must allow the drug to dissolve
c. Swallowing the medication may inactivate the medication (pH of stomach)
d. Do not eat or drink until medication has dissolved
e. None
f. All
f. All
(Non GI-Tract administration, aka Injections)
Enteral or Parental
Parental
◦ The drug is absorbed into the systemic circulation via injections
Enteral or Parental
Parental
Intravenous (FASTEST!)
Intramuscular/Subcutaneous/Intradermal
Epidural- Spinal cord injection
Enteral or Parental
Parental
Epidural
Enteral or Parental
Parental
Inhalation
Topical/Transdermal
Instillation (eye/ear/nose drops/sprays)
Enteral or Parental
Parental
•KEY CONCEPTS 1. Permeability of the Cell Membrane ◦ Lipid Soluble vs Water Soluble ◦ Blood Brain Barrier, Placenta 2. Protein Binding of drugs ◦ Free vs Bound Drug 3. Circulation/Blood Supply ◦ Diseases that alter circulation
Which ADME
DISTRIBUTION
▪PERMEABILITY OF CELL MEMBRANE
◦ Easily distribute into fatty tissues where they may store or concentrate
Water or Lipid Soluble
Lipid Soluble
▪PERMEABILITY OF CELL MEMBRANE
◦ Have the potential to cross the Blood Brain Barrier (BBB) and the Placenta
Water or Lipid Soluble
Lipid Soluble
▪PERMEABILITY OF CELL MEMBRANE
◦ Typically remain in highly vascularized spaces and can easily leave the body via elimination (urine!)
Water or Lipid Soluble
Water
▪PROTEIN BINDING
◦ Albumin is the most common blood protein
◦ Some drugs preferentially bind to protein/albumin
◦ Called
Highly or Lowly bound drugs“
Highly
Drug is not bound to albumin
◦ can distribute into extravascular tissue to its intended target
Bound drug or Free drug
Free drug
Stuck to albumin, stays in the bloodstream
◦ Cannot get to extravascular space and reach intended target
Bound drug or Free drug
Bound drug
◦ Free drug
Active or Inactive
Active
◦ Bound drug
Active or Inactive
Inactive
What are potential complications of Highly Protein Bound Drugs?
a. Deficiency in Protein/Albumin
b. Competition (two drugs can result in toxicity)
c. None
d. All
d. All
▪CIRCULATION/BLOOD SUPPLY
Vital organs like the heart, kidneys, liver, brain
Slow or Rapid
RAPID
▪CIRCULATION/BLOOD SUPPLY
Muscle, skin, fat
Slow or Rapid
SLOW
▪CIRCULATION/BLOOD SUPPLY
CONCERNS/ALTERATIONS
a. Diseases/Conditions can alter perfusion
b. Peripheral Vascular Disease, Heart Diseases (Heart Failure
c. None
d. All
d. All
Metabolism/Biotransformation Cytochrome P-450 Enzyme Induction Enzyme Inhibition Pro-Drug First Pass Effect
Which ADME
Metabolism
BIOTRANSFORMATION = which ADME
Metabolism
The biochemical alteration of a drug (substrate= target drug)
Which ADME
Metabolism
(substrate= ?)
target drug
Which of the following are true about metabolism?
a. convert drug into an active metabolite or inactive metabolite
b. Metabolites could be weaker or stronger than the original drug
c. Liver is primary organ
d. Minor roles: Skeletal muscle, Kidneys, Lungs, Plasma, Intestinal mucosa
e. None
f. All
f. All
IMPORTANT REMINDER : NOT ALL DRUGS GO THROUGH METABOLISM
True or False
True
Convert drugs to become hydrophilic and polar.
P-Glycoproteins or Cytochrome P-450 (CYP450)
Cytochrome P-450 (CYP450)
Liver enzymes target drugs (substrates)
P-Glycoproteins or Cytochrome P-450 (CYP450)
Cytochrome P-450 (CYP450)
◦ Typically target drugs that are lipophilic and non polar
P-Glycoproteins or Cytochrome P-450 (CYP450)
Cytochrome P-450 (CYP450)
Both Enzyme Induction, Enzyme Inhibition
P-Glycoproteins or Cytochrome P-450 (CYP450)
Cytochrome P-450 (CYP450)
Which are METABOLISM ALTERATION
a. Other drugs
b. Certain Foods (Grape Fruit)
c. Smoking/Alcohol
d. Patient variables
e. Diseases (liver diseases)
f. Genetics*
g. Age
h. None
i. All
i. All
METABOLISM ALTERATION
Age
◦ Infants have (limited or unlimited) liver enzymes
◦ Geriatric patients may have (less or more) liver enzyme activity
Age
◦ Infants have limited liver enzymes
◦ Geriatric patients may have less liver enzyme activity
Inducers:
PS – PORCS or PACMAN loves Grapefruit juice!
PS – PORCS
Inhibitors:
PS – PORCS or PACMAN loves Grapefruit juice!
PACMAN loves Grapefruit juice!
Inducers: PS – PORCS
P- phenytoin N- non-DHP Calcium Channel Blockers (diltiazem, verapamil) A- amiodarone R- rifampin C- carbamazepine S- St. John’s Wort (OTC herb) P- phenobarbita O- Oxcarbazepine A- azole antifungal (fluconazole, ketoconazole) C- cimetidine (H2RAs) P- protease inhibitor (HIV) M- macrolides (ACE, Azithromycin, Clarithromycin, Erythromycin) S- Smoking G- Grape Juice
P – phenytoin S – Smoking P – phenobarbital O – Oxcarbazepine R – rifampin C –carbamazepine S – St. John’s Wort (OTC herb)
Inhibitors: PACMAN loves Grapefruit juice!
P- phenytoin N- non-DHP Calcium Channel Blockers (diltiazem, verapamil) A- amiodarone R- rifampin C- carbamazepine S- St. John’s Wort (OTC herb) P- phenobarbita O- Oxcarbazepine A- azole antifungal (fluconazole, ketoconazole) C- cimetidine (H2RAs) P- protease inhibitor (HIV) M- macrolides (ACE, Azithromycin, Clarithromycin, Erythromycin) S- Smoking G- Grape Juice
P – protease inhibitor (HIV)
A – azole antifungal (fluconazole, ketoconazole)
C – cimetidine (H2RAs)
M – macrolides(ACE, Azithromycin, Clarithromycin, Erythromycin)
A – amiodarone
N – non-DHP Calcium Channel Blockers (diltiazem, verapamil)
♥’s
Grapefruit juice
HEPATOCYTES
Kidney or Liver
Liver
◦ Metabolism of drugs (CYP enzymes)
Kidney or Liver
Liver
◦ Metabolism of hormones
Kidney or Liver
Liver
◦ Protein Synthesis and degradation
Kidney or Liver
Liver
◦ Coagulation- uses Vitamin K to make clotting factors
Kidney or Liver
Liver
◦ Albumin
Kidney or Liver
Liver
◦ Glycogen storage (Glycogenesis)
Kidney or Liver
Liver
◦ Cholesterol- Lipids + Bile Acid metabolism
Kidney or Liver
Liver
▪ Cirrhosis
Kidney or Liver
Liver
▪ Hepatotoxicity
Kidney or Liver
Liver
▪ DRUGS (Drug Induced Liver Injury- DILI), Alcoholic Liver Disease, Hepatitis, more!
Kidney or Liver
Liver
◦ Dark urine- (bilirubin mixes with urine)
Kidney or Liver
Liver
Jaundice (yellow eyes, liver no longer filters bilirubin from blood, or can’t conjugate it so it can’t be removed via bile)
Kidney or Liver
Liver
Swelling of abdomen (no longer making sufficient albumin)
Kidney or Liver
Liver
Bruising/Bleeding (lack of clotting factors)
◦ Fatigue
Kidney or Liver
Liver
Ammonia can concentrate (liver normally converts to urea)
Kidney or Liver
Liver
◦ Ammonia accumulation- neurological changes- encephalopathy
Kidney or Liver
Liver
PHARMACOKINETICS: METABOLISM
Kidney or Liver
Liver
PHARMACOKINETICS: ELIMINATION
Kidney or Liver
Kidney
Other Mechanisms:
◦ Liver, Breast milk, Sweat, Bowel (biliary excretion, enterohepatic recirculation)
METABOLISM or ELIMINATION
ELIMINATION
Injury to the kidney which results in a
sudden elevated SCr/BUN and a decreased eGFR/CrCl
Chronic Kidney Disease, Acute Kidney Injury, or Nephrotoxicity
Acute Kidney Injury
Chronically elevated SCr/BUN,
decreased eGFR/CrCl
Chronic Kidney Disease, Acute Kidney Injury, or Nephrotoxicity
Chronic Kidney Disease
Certain drugs may be harmful to the kidneys.
We call the resulting damage, nephrotoxicity. Clinically, this is also called an acute kidney injury
Chronic Kidney Disease, Acute Kidney Injury, or Nephrotoxicity
Nephrotoxicity